#	Pagina
attuale pagina	/open-h2020/projects/201070/index.html
-1	/open-h2020/projects/195185/index.html

Opendata, web and dolomites

CLLassify SIGNED

Innovative risk assessment for individualizing treatment in chronic lymphocytic leukemia

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

CLLassify project word cloud

Explore the words cloud of the CLLassify project. It provides you a very rough idea of what is the project "CLLassify" about.

cll fashion leukemia statistical guarantee health benefits personalize patient lymphocytic personalized improvement innovative background point prediction cllassify proposing individual multidisciplinary career techniques treatment prospects prognosis classification chronic successful attempt diagnosis time patients pioneering supervisor faces societal efficient expertise society

Project "CLLassify" data sheet

The following table provides information about the project.

Coordinator	ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS Organization address address: CHARILAOU THERMI ROAD 6 KM city: THERMI THESSALONIKI postcode: 57001 website: www.certh.gr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Greece [EL]
Project website	http://cllassify.gr/
Total cost	164˙653 €
EC max contribution	164˙653 € (100%)
Programme	1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
Code Call	H2020-MSCA-IF-2015
Funding Scheme	MSCA-IF-EF-ST
Starting year	2016
Duration (year-month-day)	from 2016-04-01 to 2018-03-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS Organization address address: CHARILAOU THERMI ROAD 6 KM city: THERMI THESSALONIKI postcode: 57001 website: www.certh.gr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	EL (THERMI THESSALONIKI)	coordinator	164˙653.00

Map

Project objective

Chronic lymphocytic leukemia faces high-challenging and timely problems related to the classification and efficient prognosis of patients at the time of diagnosis and the attempt to personalize the treatment. CLLassify addresses these issues in a pioneering fashion within a multidisciplinary collaboration, proposing an improved classification of the patients, based on innovative statistical techniques as well as the novel aspect of personalized prediction of the need for treatment at a specific time point for the individual patient. The statistical background of the applicant, together with the expertise of his supervisor in CLL, guarantee the successful implementation of this project. This will result both in significant health advances and societal benefits for the European society at large raising the project at the level of a European priority, and to significant improvement of the applicant’s career prospects within Europe.

Publications

List of publications.
year	authors and title	journal	last update
2016	P. Baliakas, A. Puiggros, A. Xochelli, L.-A. Sutton, F. Nguyen-Khac, A. Gardiner, K. Plevova, E. Minga, A. Hadzidimitriou, R. Walewska, H. McCarthy, M. Ortega, R. Collado, T. Gonzalez, I. Granada, E. Luno, J. KotaÂ kova, T. Moysiadis, Z. Davis, N. Stavroyianni, A. Anagnostopoulos, J. C. Strefford, S. Pospisilova, F. Davi, A. Athanasiadou, R. Rosenquist, D. Oscier, B. Espinet, K. Stamatopoulos Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference published pages: e299-e302, ISSN: 0390-6078, DOI: 10.3324/haematol.2015.140202	Haematologica 101/7	2019-06-13
2016	Nikos Papakonstantinou, Stavroula Ntoufa, Elisavet Chartomatsidou, Konstantia Kotta, Andreas Agathangelidis, Lefki Giassafaki, Tzeni Karamanli, Panagiota Bele, Theodoros Moysiadis, Panagiotis Baliakas, Lesley Ann Sutton, Niki Stavroyianni, Achilles Anagnostopoulos, Antonios M. Makris, Paolo Ghia, Richard Rosenquist, Kostas Stamatopoulos The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia published pages: 35946â€“35959, ISSN: 1949-2553, DOI: 10.18632/oncotarget.9371	Oncotarget 7/24	2019-06-13

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLLASSIFY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLLASSIFY" are provided by the European Opendata Portal: CORDIS opendata.